Investors Buy UnitedHealth Group Incorporated (NYSE:UNH) on Weakness
Traders bought shares of UnitedHealth Group Incorporated (NYSE:UNH) on weakness during trading on Wednesday. $103.05 million flowed into the stock on the tick-up and $74.38 million flowed out of the stock on the tick-down, for a money net flow of $28.67 million into the stock. Of all companies tracked, UnitedHealth Group had the 20th highest net in-flow for the day. UnitedHealth Group traded down ($0.07) for the day and closed at $194.83
A number of research firms have recently issued reports on UNH. UBS AG restated a “buy” rating and issued a $194.00 target price (up previously from $193.00) on shares of UnitedHealth Group in a report on Saturday, April 22nd. Zacks Investment Research upgraded UnitedHealth Group from a “hold” rating to a “buy” rating and set a $215.00 price objective for the company in a report on Tuesday, August 1st. Leerink Swann reiterated an “outperform” rating on shares of UnitedHealth Group in a report on Friday, June 9th. Citigroup Inc. increased their price objective on UnitedHealth Group from $195.00 to $213.00 and gave the stock a “buy” rating in a report on Wednesday, July 19th. Finally, BidaskClub upgraded UnitedHealth Group from a “hold” rating to a “buy” rating in a report on Friday, June 9th. One research analyst has rated the stock with a hold rating and twenty-four have given a buy rating to the stock. The company currently has an average rating of “Buy” and a consensus price target of $200.24.
The stock has a market capitalization of $191.91 billion, a P/E ratio of 23.41 and a beta of 0.64. The stock’s 50-day moving average price is $187.91 and its 200-day moving average price is $173.50.
UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings results on Tuesday, July 18th. The healthcare conglomerate reported $2.46 EPS for the quarter, beating the Zacks’ consensus estimate of $2.38 by $0.08. UnitedHealth Group had a net margin of 4.32% and a return on equity of 21.52%. The company had revenue of $50.05 billion during the quarter, compared to analyst estimates of $49.97 billion. During the same period in the prior year, the business posted $1.96 EPS. The firm’s revenue was up 7.7% compared to the same quarter last year. On average, equities analysts forecast that UnitedHealth Group Incorporated will post $9.87 EPS for the current fiscal year.
In other UnitedHealth Group news, Director William C. Ballard, Jr. sold 5,000 shares of the company’s stock in a transaction on Wednesday, June 7th. The shares were sold at an average price of $182.64, for a total value of $913,200.00. Following the completion of the transaction, the director now directly owns 75,735 shares in the company, valued at approximately $13,832,240.40. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Gail R. Wilensky sold 5,540 shares of the company’s stock in a transaction on Friday, June 2nd. The stock was sold at an average price of $178.74, for a total transaction of $990,219.60. Following the completion of the transaction, the director now owns 60,516 shares of the company’s stock, valued at $10,816,629.84. The disclosure for this sale can be found here. Insiders have sold a total of 15,540 shares of company stock valued at $2,873,320 over the last quarter. 0.89% of the stock is currently owned by company insiders.
A number of hedge funds and other institutional investors have recently modified their holdings of UNH. Patriot Financial Group Insurance Agency LLC raised its position in shares of UnitedHealth Group by 1,722.9% in the first quarter. Patriot Financial Group Insurance Agency LLC now owns 638 shares of the healthcare conglomerate’s stock valued at $106,000 after buying an additional 603 shares during the period. Blue Chip Partners Inc. bought a new position in shares of UnitedHealth Group during the second quarter valued at approximately $110,000. Cribstone Capital Management LLC raised its position in shares of UnitedHealth Group by 22.6% in the first quarter. Cribstone Capital Management LLC now owns 678 shares of the healthcare conglomerate’s stock valued at $113,000 after buying an additional 125 shares during the period. Kings Point Capital Management raised its position in shares of UnitedHealth Group by 27.9% in the first quarter. Kings Point Capital Management now owns 687 shares of the healthcare conglomerate’s stock valued at $113,000 after buying an additional 150 shares during the period. Finally, Mitsubishi UFJ Securities Holdings Co. Ltd. raised its position in shares of UnitedHealth Group by 433.3% in the second quarter. Mitsubishi UFJ Securities Holdings Co. Ltd. now owns 640 shares of the healthcare conglomerate’s stock valued at $119,000 after buying an additional 520 shares during the period. Institutional investors and hedge funds own 86.37% of the company’s stock.
TRADEMARK VIOLATION WARNING: This story was published by Watch List News and is owned by of Watch List News. If you are reading this story on another domain, it was illegally copied and republished in violation of United States & international trademark and copyright legislation. The correct version of this story can be accessed at https://www.watchlistnews.com/investors-buy-unitedhealth-group-incorporated-nyseunh-on-weakness/1466682.html.
About UnitedHealth Group
UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.
Receive News & Ratings for UnitedHealth Group Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Incorporated and related companies with Analyst Ratings Network's FREE daily email newsletter.